Dina Pfeifer

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

Steven Black, Juhani Eskola, Claire-Anne Siegrist et al. · The Lancet · 2009 · 255 citations · Full text

Vaccination, Vaccine Safety, Cross-protection +8

Influenza vaccine in pregnancy: policy and research strategies

Mark C. Steinhoff, Noni E. MacDonald, Dina Pfeifer et al. · The Lancet · 2014 · 34 citations

Vaccination, Vaccinology, Maternal Immunization +5

Guillain-Barré Syndrome Following Influenza Vaccination: Causal or Coincidental?

James J. Sejvar, Dina Pfeifer, Lawrence B. Schonberger · Current Infectious Disease Reports · 2011 · 29 citations

Vaccination, Vaccine Efficacy, Influenza Vaccine +4

Call for action: Health services in the European region must adopt integrated care models to manage Post-Covid-19 Condition

Hans Kluge, Natasha Azzopardi‐Muscat, Satish Mishra et al. · The Lancet Regional Health - Europe · 2022 · 22 citations · Full text

Disease Management, Integrated Care, Care Models +10

Sudden death from trophoblastic embolism in pregnancy

Josip Đelmiš, Dina Pfeifer, Marina Ivanišević et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2000 · 21 citations

Postpartum Hemorrhage, Abortion, Sudden Death +9